SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2023 and 2022:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2023
Revenue	$	20,963,661		$	28,117		$	12,758		$	1,083,971		$	22,088,507
Cost of Sales		(13,915,144	)		(9,145	)		(54,529	)		(597,391	)		(14,576,209	)
Gross Margin		7,048,517			18,972			(41,771	)		486,580			7,512,298
Operating Expenses		(1,312,024	)		(468,679	)		(869,683	)		(7,734,566	)		(10,384,952	)
Operating Income (Loss)		5,736,493			(449,707	)		(911,454	)		(7,247,986	)		(2,872,654	)
Other Income (Expense)		47,363			(6,066,133	)		(593,994	)		(51,700,965	)		(58,313,729	)
Net Income (Loss) Before Income Tax		5,783,856			(6,515,840	)		(1,505,448	)		(58,948,951	)		(61,186,383	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2022
Revenue	$	3,088,628		$	69,915		$	753,651		$	568,248		$	4,480,442
Cost of Sales		(3,016,200	)		(23,423	)		(523,534	)		(168,833	)		(3,731,990	)
Gross Margin		72,428			46,492			230,117			399,415			748,452
Operating Expenses		(1,479,674	)		(414,167	)		(850,044	)		(5,093,941	)		(7,837,826	)
Operating Income (Loss)		(1,407,246	)		(367,675	)		(619,927	)		(4,694,526	)		(7,089,374	)
Other Income (Expense)		5,885			(1,359,977	)		(4,669,309	)		(33,099,730	)		(39,123,131	)
Net Income (Loss) Before Income Tax		(1,401,361	)		(1,727,652	)		(5,289,236	)		(37,794,256	)		(46,212,505	)
December 31, 2023
Cash and Restricted Cash	$	3,323,210		$	430,807		$	568,702		$	23,566,574		$	27,889,293
Total Assets		62,989,233			5,845,269			2,450,876			55,028,650			126,314,028
December 31, 2022	$	2,592,577		$	514,260		$	1,338,404		$	14,076,662		$	18,521,903
Cash and Restricted Cash		57,951,324			3,184,416			4,861,615			87,492,981			153,490,336
Total Assets